Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2014:167:312-21.
doi: 10.1016/j.jad.2014.05.031. Epub 2014 May 29.

The Korean Medication Algorithm for Depressive Disorder: second revision

Jeong Seok Seo  1 , Hoo Rim Song  2 , Hwang Bin Lee  3 , Young-Min Park  4 , Jeong-Wan Hong  5 , Won Kim  6 , Hee-Ryung Wang  2 , Eun-Sung Lim  7 , Jong-Hyun Jeong  8 , Duk-In Jon  9 , Kyung Joon Min  10 , Young Sup Woo  2 , Won-Myong Bahk  11
Affiliations
Practice Guideline

The Korean Medication Algorithm for Depressive Disorder: second revision

Jeong Seok Seo et al. J Affect Disord. 2014.

Abstract

Aim: This study constitutes a revision of the guidelines for the treatment of major depressive disorder (MDD) issued by the Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD) 2006. In incorporates changes in the experts׳ consensus that occurred between 2006 and 2012 as well as information regarding newly developed and recently published clinical trials.

Methods: Using a 44-item questionnaire, an expert consensus was obtained on pharmacological treatment strategies for (1) non-psychotic MDD, (2) psychotic MDD, (3) dysthymia and depression subtypes, (4) continuous and maintenance treatment, and (5) special populations; consensus was also obtained regarding (6) the choice of an antidepressant (AD) in the context of safety and adverse effects, and (7) non-pharmacological biological therapies.

Results: AD monotherapy was recommended as the first-line strategy for nonpsychotic depression in adults, children and adolescents, elderly adults, and patients with postpartum depression or premenstrual dysphoric disorder. The combination of AD and atypical antipsychotics (AAP) was recommended for psychotic depression. The duration of the initial AD treatment for psychotic depression depends on the number of depressive episodes. Most experts recommended stopping the initial AD and AAP therapy after a certain period in patients with one or two depressive episodes. However, for those with three or more episodes, maintenance of the initial treatment was recommended for as long as possible. Monotherapy with various selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) was recommended for dysthymic disorder and melancholic type MDD.

Conclusion: The pharmacological treatment strategy of KMAP-DD 2012 is similar to that of KMAP-DD 2006; however, the preference for the first-line use of AAPs was stronger in 2012 than in 2006.

Keywords: Algorithm; Depressive disorder; Guideline; Revision.

PubMed Disclaimer

Publication types

MeSH terms